ES2131083T3 - Nuevas formulaciones de morfina para su utilizacion por administracion iontoforetica. - Google Patents

Nuevas formulaciones de morfina para su utilizacion por administracion iontoforetica.

Info

Publication number
ES2131083T3
ES2131083T3 ES93107160T ES93107160T ES2131083T3 ES 2131083 T3 ES2131083 T3 ES 2131083T3 ES 93107160 T ES93107160 T ES 93107160T ES 93107160 T ES93107160 T ES 93107160T ES 2131083 T3 ES2131083 T3 ES 2131083T3
Authority
ES
Spain
Prior art keywords
morphine
administration
iontoforetic
new formulations
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93107160T
Other languages
English (en)
Inventor
Robert L Stephen
Cesare Bonezzi
Cino Rossi
Silvio Eruzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Physion Srl
Original Assignee
Physion Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Physion Srl filed Critical Physion Srl
Application granted granted Critical
Publication of ES2131083T3 publication Critical patent/ES2131083T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA FORMULA DE MORFINA PARA USO POR ADMINISTRACION ELECTROMOTIVA QUE COMPRENDE LAS SALES DE CITRATO DE MORFINA DE LA FORMULA, EN DONDE M ES LA MORFINA PROTONATADA, CT ES UN CATION FISIOLOGICAMENTE ACEPTABLE, N ES UN ENTERO O NUMERO FRACCIONARIO MAS GRANDE QUE 0 Y MENOS O IGUAL QUE 3, Y P ES UN ENTERO DE 1 A 3.
ES93107160T 1993-05-03 1993-05-03 Nuevas formulaciones de morfina para su utilizacion por administracion iontoforetica. Expired - Lifetime ES2131083T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93107160A EP0623345B1 (en) 1993-05-03 1993-05-03 New morphine formulations for use by iontophoretic administration

Publications (1)

Publication Number Publication Date
ES2131083T3 true ES2131083T3 (es) 1999-07-16

Family

ID=8212866

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93107160T Expired - Lifetime ES2131083T3 (es) 1993-05-03 1993-05-03 Nuevas formulaciones de morfina para su utilizacion por administracion iontoforetica.

Country Status (4)

Country Link
EP (1) EP0623345B1 (es)
AT (1) ATE178797T1 (es)
DE (1) DE69324476T2 (es)
ES (1) ES2131083T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6650934B2 (en) 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method

Also Published As

Publication number Publication date
DE69324476D1 (de) 1999-05-20
EP0623345B1 (en) 1999-04-14
ATE178797T1 (de) 1999-04-15
DE69324476T2 (de) 1999-09-02
EP0623345A1 (en) 1994-11-09

Similar Documents

Publication Publication Date Title
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE69500813D1 (de) Substituierte (5,6)-Dihydronaphthalinylverbindungen mit retinoid-artiger Wirkung
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
NO921413L (no) Pyrazolopyridin-forbindelser og fremgangsmaate for fremstilling derav
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0395441A3 (en) Treating agent for osteoarthritis
ES2163425T3 (es) Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica.
NZ236605A (en) 2-aminopyrimidine-4-carboxamide derivatives, preparation and pharmaceutical compositions thereof
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
ZA832292B (en) Salicylic acid derivatives,processes for their preparation,pharmaceutical for mulations based on these compounds and their use
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ATE178797T1 (de) Neue morphinzusammensetzungen für iontophoretische verabreichung
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
TW261605B (es)
DE69006107D1 (de) Phenethanolaminderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
IE822853L (en) 1-piperazino carboxylates
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
SE8500962L (sv) Nitrodiarylsulfoxidderivat, forfarande for framstellning derav och farmaceutiska och pesticida kompositioner innehallande dem som aktiv bestandsdel
ATA262787A (de) Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung
ITMI912238A1 (it) Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche
PT90140A (pt) Processo para a preparacao de preparados para cintigrafia ossea contendo tc-99m-omega-alquilfosfinico-1-hidroxialcano-1,1-difosfonatos
ES540693A0 (es) Un procedimiento de preparar sales quinato de alfa-2-piperi-dinil-2,8-bis(trifluorometil)-4-quinolino-metanol

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 623345

Country of ref document: ES